Fund shareholders of Alnylam Pharmaceuticals Inc
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 760
- Of which ETFs
- 211 549 other funds
- Value held
- 24.8B $ 1.4B SEK · 14.6M €
- Share of capital
- 56.7 % of 133.8M shares on Jul 24, 2026
760 funds hold this company. This table lists the 756 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Growth Fund of America Growth Fund of America | 8,024,520 | 2.7B $ | 0.81 % | 6.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,215,761 | 1.4B $ | 0.07 % | 3.15 % | as of Mar 31, 2026 ↗ |
| AMCAP Fund AMCAP Fund | 3,744,659 | 1.2B $ | 1.33 % | 2.80 % | as of Feb 28, 2026 ↗ |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,864,161 | 947.7M $ | 0.48 % | 2.14 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1 | 2,793,810 | 924.4M $ | 0.25 % | 2.09 % | as of Mar 31, 2026 ↗ |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 2,036,592 | 673.8M $ | 0.63 % | 1.52 % | as of Mar 31, 2026 ↗ |
| Investment Co of America Investment Co of America | 1,947,787 | 644.5M $ | 0.39 % | 1.46 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 1,715,880 | 567.7M $ | 0.86 % | 1.28 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,670,679 | 517.1M $ | 1.40 % | 1.25 % | as of Apr 30, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 1,593,724 | 493.2M $ | 1.22 % | 1.19 % | as of Apr 30, 2026 ↗ |
| VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,565,234 | 517.9M $ | 0.16 % | 1.17 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,480,260 | 489.8M $ | 0.60 % | 1.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,300,974 | 433.1M $ | 0.53 % | 0.97 % | as of Feb 28, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 1,276,486 | 422.4M $ | 0.85 % | 0.95 % | as of Mar 31, 2026 ↗ |
| Dodge & Cox Stock Fund Dodge & Cox Funds | 1,233,200 | 408M $ | 0.36 % | 0.92 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 1,202,994 | 398M $ | 0.25 % | 0.90 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,166,560 | 386M $ | 1.71 % | 0.87 % | as of Mar 31, 2026 ↗ |
| New Perspective Fund New Perspective Fund | 1,020,320 | 337.6M $ | 0.22 % | 0.76 % | as of Mar 31, 2026 ↗ |
| VANGUARD MID-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,008,744 | 333.8M $ | 1.14 % | 0.75 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 979,642 | 324.1M $ | 3.99 % | 0.73 % | as of Mar 31, 2026 ↗ |
| New Economy Fund New Economy Fund | 867,315 | 288.7M $ | 0.64 % | 0.65 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 850,606 | 281.4M $ | 1.51 % | 0.64 % | as of Mar 31, 2026 ↗ |
| Ultra Fund American Century Mutual Funds, Inc. | 747,000 | 231.2M $ | 0.87 % | 0.56 % | as of Apr 30, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 700,981 | 231.9M $ | 2.03 % | 0.52 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 691,763 | 230.3M $ | 0.56 % | 0.52 % | as of Feb 28, 2026 ↗ |
| American Funds Fundamental Investors American Funds Fundamental Investors | 600,000 | 198.5M $ | 0.13 % | 0.45 % | as of Mar 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 573,365 | 177.5M $ | 0.19 % | 0.43 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 569,120 | 189.5M $ | 0.09 % | 0.43 % | as of Feb 28, 2026 ↗ |
| Capital Group Growth ETF Capital Group Growth ETF | 557,684 | 185.7M $ | 0.92 % | 0.42 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. GROWTH FUND VANGUARD WORLD FUND | 554,294 | 184.5M $ | 0.42 % | 0.41 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 531,894 | 176M $ | 1.62 % | 0.40 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 511,131 | 169.1M $ | 0.15 % | 0.38 % | as of Mar 31, 2026 ↗ |
| Invesco American Franchise Fund AIM Counselor Series Trust (Invesco Counselor Series Trust) | 504,640 | 168M $ | 1.02 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Invesco NASDAQ 100 ETF Invesco Exchange-Traded Fund Trust II | 502,493 | 167.3M $ | 0.24 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 496,683 | 165.4M $ | 3.09 % | 0.37 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Growth Opportunities Fund Fidelity Advisor Series I | 490,835 | 163.4M $ | 0.56 % | 0.37 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 484,627 | 160.3M $ | 0.33 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 469,553 | 145.3M $ | 0.29 % | 0.35 % | as of Apr 30, 2026 ↗ |
| JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust | 447,815 | 148.2M $ | 0.73 % | 0.33 % | as of Mar 31, 2026 ↗ |
| Heritage Fund American Century Mutual Funds, Inc. | 413,220 | 127.9M $ | 2.38 % | 0.31 % | as of Apr 30, 2026 ↗ |
| Asset Allocation Fund AMERICAN FUNDS INSURANCE SERIES | 405,917 | 134.3M $ | 0.51 % | 0.30 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 393,742 | 131.1M $ | 0.65 % | 0.29 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 381,380 | 126.2M $ | 0.54 % | 0.29 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 380,807 | 126M $ | 0.91 % | 0.28 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Mid Cap Growth Fund Federated Hermes Equity Funds | 378,793 | 117.2M $ | 1.84 % | 0.28 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 366,500 | 122M $ | 0.53 % | 0.27 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 340,000 | 113.2M $ | 1.83 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 339,486 | 105.1M $ | 5.52 % | 0.25 % | as of Apr 30, 2026 ↗ |
| MFS Mid Cap Growth Fund MFS Series Trust IV | 331,878 | 110.5M $ | 0.80 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 323,031 | 107.5M $ | 0.51 % | 0.24 % | as of Feb 28, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 308,886 | 102.2M $ | 0.39 % | 0.23 % | as of Mar 31, 2026 ↗ |
| JPMorgan Nasdaq Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 295,318 | 97.7M $ | 0.29 % | 0.22 % | as of Mar 31, 2026 ↗ |
| American Funds Global Balanced Fund American Funds Global Balanced Fund | 269,513 | 83.4M $ | 0.26 % | 0.20 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 264,406 | 87.5M $ | 1.18 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 261,731 | 86.6M $ | 0.26 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 253,288 | 84.3M $ | 0.17 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Carillon Eagle Mid Cap Growth Fund Carillon Series Trust | 251,940 | 83.4M $ | 1.75 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 247,151 | 82.3M $ | 0.07 % | 0.18 % | as of Feb 28, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 228,800 | 76.2M $ | 1.81 % | 0.17 % | as of Feb 27, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 228,000 | 70.6M $ | 2.44 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 226,759 | 75M $ | 0.56 % | 0.17 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 226,246 | 70M $ | 0.31 % | 0.17 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 208,960 | 69.6M $ | 0.15 % | 0.16 % | as of Feb 28, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 208,210 | 68.9M $ | 1.72 % | 0.16 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 207,149 | 69M $ | 1.06 % | 0.15 % | as of Feb 27, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 202,492 | 67M $ | 2.95 % | 0.15 % | as of Mar 31, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 200,888 | 633.2M SEK | 0.05 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 195,478 | 65.1M $ | 0.07 % | 0.15 % | as of Feb 28, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 192,788 | 63.8M $ | 2.05 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fundamental Large Cap Core Fund John Hancock Investment Trust | 191,527 | 59.3M $ | 0.94 % | 0.14 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 188,814 | 62.5M $ | 1.47 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Equity Growth Fund Fidelity Advisor Series I | 187,899 | 62.6M $ | 0.52 % | 0.14 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 185,329 | 61.3M $ | 0.48 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 180,268 | 55.8M $ | 0.13 % | 0.13 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 174,532 | 57.7M $ | 0.88 % | 0.13 % | as of Mar 31, 2026 ↗ |
| VIP Growth Portfolio Variable Insurance Products Fund | 173,424 | 57.4M $ | 0.54 % | 0.13 % | as of Mar 31, 2026 ↗ |
| JPMorgan Active Growth ETF J.P. Morgan Exchange-Traded Fund Trust | 168,491 | 55.7M $ | 0.68 % | 0.13 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 166,375 | 55M $ | 0.07 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 161,841 | 53.5M $ | 0.45 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Large Cap Stock Fund Fidelity Hastings Street Trust | 158,850 | 52.6M $ | 0.21 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Franklin Small-Mid Cap Growth Fund Franklin Strategic Series | 158,320 | 49M $ | 1.39 % | 0.12 % | as of Apr 30, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 155,683 | 51.5M $ | 0.08 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 154,835 | 51.2M $ | 1.50 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Nomura Mid Cap Growth Fund IVY FUNDS | 153,221 | 50.7M $ | 1.69 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Mid Cap ETF Fidelity Covington Trust | 153,038 | 50.6M $ | 0.86 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Strategies Fund Fidelity Mt. Vernon Street Trust | 150,480 | 50.1M $ | 1.22 % | 0.11 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 149,404 | 49.4M $ | 0.79 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Focused Dynamic Growth Fund American Century Growth Funds, Inc. | 144,066 | 44.6M $ | 2.10 % | 0.11 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 140,182 | 46.4M $ | 1.68 % | 0.10 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 137,700 | 45.6M $ | 0.06 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 135,617 | 45.1M $ | 0.07 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 133,812 | 41.4M $ | 1.25 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Blue Chip Growth K6 Fund Fidelity Securities Fund | 132,122 | 40.9M $ | 0.21 % | 0.10 % | as of Apr 30, 2026 ↗ |
| ClearBridge Value Fund Legg Mason Global Asset Management Trust | 125,000 | 38.7M $ | 0.93 % | 0.09 % | as of Apr 30, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 121,989 | 40.4M $ | 1.47 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 121,600 | 40.2M $ | 0.87 % | 0.09 % | as of Mar 31, 2026 ↗ |
| ProShares UltraPro QQQ ProShares Trust | 113,590 | 37.8M $ | 0.14 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 105,104 | 32.5M $ | 0.06 % | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 103,095 | 31.9M $ | 0.04 % | 0.08 % | as of Apr 30, 2026 ↗ |
| First Trust Nasdaq-100 Select Equal Weight ETF First Trust Exchange-Traded Fund | 102,576 | 33.9M $ | 2.16 % | 0.08 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 5.52 % | as of Apr 30, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.84 % | as of Apr 30, 2026 ↗ |
| Nestyield Dynamic Income ETF Tidal Trust III | 4.66 % | as of Feb 28, 2026 ↗ |
| NestYield Visionary ETF Tidal Trust III | 4.62 % | as of Feb 28, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 4.14 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 4.11 % | as of Mar 31, 2026 ↗ |
| Nestyield Total Return Guard ETF Tidal Trust III | 4.06 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.99 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND VANGUARD VALLEY FORGE FUNDS | 3.46 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Declared shareholders of Alnylam Pharmaceuticals Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 11.00 % | 14,640,525 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital World Investors | 8.20 % | 10,916,799 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 7.10 % | 9,471,181 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.35 % | 7,104,536 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Alnylam Pharmaceuticals Inc
33 funds declare 42 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Alnylam Pharmaceuticals Inc". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076